| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | Dec 9, 2024 | Allogene Therapeutics, Inc. | Director | Sell | 26.3 | -9,221 | -2.91% | ✗ | $19.9K |
| May 30, 2024 | Jun 3, 2024 | Allogene Therapeutics, Inc. | Director | Sell | 26.3 | -11,200 | -4.20% | ✗ | $26.2K |
| Oct 15, 2018 | Oct 17, 2018 | Allogene Therapeutics, Inc. | Director | Buy | 97.5 | +30,000 | 100.00% | ✗ | $540K |